Cargando…
The Crying Need for a Better Response Assessment in Rectal Cancer
Since total neoadjuvant treatment achieves almost 30% pathologic complete response, organ preservation has been increasingly debated for good responders after neoadjuvant treatment for patients diagnosed with rectal cancer. Two organ preservation strategies are available: a watch and wait strategy a...
Autores principales: | Amintas, Samuel, Giraud, Nicolas, Fernandez, Benjamin, Dupin, Charles, Denost, Quentin, Garant, Aurelie, Frulio, Nora, Smith, Denis, Rullier, Anne, Rullier, Eric, Vuong, Te, Dabernat, Sandrine, Vendrely, Véronique |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643426/ https://www.ncbi.nlm.nih.gov/pubmed/37702885 http://dx.doi.org/10.1007/s11864-023-01125-9 |
Ejemplares similares
-
Benchmarking trial between France and Australia comparing management of primary rectal cancer beyond TME and locally recurrent rectal cancer (PelviCare Trial): rationale and design
por: Denost, Quentin, et al.
Publicado: (2016) -
Next-Generation Cancer Biomarkers: Extracellular Vesicle DNA as a Circulating Surrogate of Tumor DNA
por: Amintas, Samuel, et al.
Publicado: (2021) -
Image-Guided Brachytherapy for Rectal Cancer: Reviewing the Past Two Decades of Clinical Investigation
por: Vuong, Te, et al.
Publicado: (2022) -
Tumor‐proximal liquid biopsy to improve diagnostic and prognostic performances of circulating tumor cells
por: Buscail, Etienne, et al.
Publicado: (2019) -
Circulating Tumor Cell Clusters: United We Stand Divided We Fall
por: Amintas, Samuel, et al.
Publicado: (2020)